Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Med Princ Pract ; 26(1): 50-56, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-27780164

RESUMEN

OBJECTIVE: To investigate the symptoms of lung cancer in Turkey and to evaluate approaches to alleviate these symptoms. SUBJECTS AND METHODS: This study included 1,245 lung cancer patients from 26 centers in Turkey. Demographic characteristics as well as information regarding the disease and treatments were obtained from medical records and patient interviews. Symptoms were evaluated using the Edmonton Symptom Assessment Scale (ESAS) and were graded on a scale between 0 and 10 points. Data were compared using the χ2, Student t, and Mann-Whitney U tests. Potential predictors of symptoms were analyzed using logistic regression analysis. RESULTS: The most common symptom was tiredness (n = 1,002; 82.1%), followed by dyspnea (n = 845; 69.3%), appetite loss (n = 801; 65.7%), pain (n = 798; 65.4%), drowsiness (n = 742; 60.8%), anxiety (n = 704; 57.7%), depression (n = 623; 51.1%), and nausea (n = 557; 45.5%). Of the 1,245 patients, 590 (48.4%) had difficulty in initiating or maintaining sleep. The symptoms were more severe in stages III and IV. Logistic regression analysis indicated a clear association between demographic characteristics and symptom distress, as well as between symptom distress (except nausea) and well-being. Overall, 804 (65.4%) patients used analgesics, 630 (51.5%) received treatment for dyspnea, 242 (19.8%) used enteral/parenteral nutrition, 132 (10.8%) used appetite stimulants, and 129 (10.6%) used anxiolytics/antidepressants. Of the 799 patients who received analgesics, 173 (21.7%) reported that their symptoms were under control, and also those on other various treatment modalities (dyspnea: 78/627 [12.4%], appetite stimulant: 25/132 [18.9%], and anxiolytics/antidepressants: 25/129 [19.4%]) reported that their symptoms were controlled. CONCLUSION: In this study, the symptoms progressed and became more severe in the advanced stages of lung cancer, and palliative treatment was insufficient in most of the patients in Turkey.


Asunto(s)
Neoplasias Pulmonares/complicaciones , Neoplasias Pulmonares/psicología , Neoplasias de Células Escamosas , Cuidados Paliativos , Adulto , Anciano , Analgésicos/uso terapéutico , Comorbilidad , Disnea/complicaciones , Disnea/epidemiología , Fatiga/complicaciones , Fatiga/epidemiología , Femenino , Humanos , Entrevistas como Asunto , Modelos Logísticos , Neoplasias Pulmonares/terapia , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Dolor/complicaciones , Dolor/epidemiología , Calidad de Vida , Turquía/epidemiología
2.
Genet Mol Res ; 15(1)2016 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-27050960

RESUMEN

The aim of the present study was to investigate DNA damage in peripheral blood lymphocytes of breast cancer (BC) patients before and after administration of chemotherapy. We analyzed the frequency of sister chromatid exchange (SCE), occurrence of micronuclei (MN), and lymphocyte proliferation rate index (PRI) as cytogenetic markers in 28 female BC patients before and after chemotherapy, and in 20 age-matched healthy female volunteers. Prior to treatment, BC patients showed significantly increased background levels of SCE and MN, and lowered PRIs compared to healthy women. In comparison with pre-treatment levels, SCE and MN frequencies were significantly elevated and PRI reduced in blood samples collected after chemotherapy. Our findings indicate that SCE, MN, and PRI may serve as sensitive biomarkers for routine detection of the genetic abnormalities that may occur following administration of antineoplastic drugs in the clinical setting, as well as for the monitoring of high-risk patients receiving chemotherapy for BC.


Asunto(s)
Neoplasias de la Mama/sangre , Quimioterapia Adyuvante/efectos adversos , Linfocitos/efectos de los fármacos , Intercambio de Cromátides Hermanas/efectos de los fármacos , Adulto , Anciano , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/genética , Estudios de Casos y Controles , Núcleo Celular/efectos de los fármacos , Núcleo Celular/patología , Daño del ADN , Femenino , Humanos , Linfocitos/patología , Persona de Mediana Edad
3.
Genet Mol Res ; 10(2): 828-33, 2011 May 10.
Artículo en Inglés | MEDLINE | ID: mdl-21574139

RESUMEN

Oxidative stress may be contributory to the pathophysiology of the abnormalities that underlie the clinical course of sickle cell anemia. We looked for a possible genetic association between the functional polymorphism Ala-9Val in the human Mn-SOD gene and sickle cell anemia. One hundred and twenty-seven patients with sickle cell anemia and 127 healthy controls were recruited into the study. Alanine versus valine polymorphism in the signal peptide of the Mn-SOD gene was evaluated using a primer pair to amplify a 107-bp fragment followed by digestion with the restriction enzyme NgoMIV. In the sickle cell anemia patients, the frequency of Val/Val genotype was approximately 1.4-fold lower and that of Ala/Val was 1.3-fold higher compared to the controls. No significant difference in genotype frequencies was found between patients and controls (χ(2) = 4.561, d.f. = 2, P = 0.101). The Val-9 was the most common allele in patient and healthy subjects. No significant difference in allele frequencies was found between patients and controls (χ(2) = 1.496, d.f. = 1, P = 0.221). We conclude that the Mn-SOD gene polymorphism is not associated with sickle cell anemia.


Asunto(s)
Sustitución de Aminoácidos/genética , Anemia de Células Falciformes/genética , Polimorfismo Genético , Superóxido Dismutasa/genética , Adolescente , Adulto , Alanina/genética , Alelos , Anemia de Células Falciformes/enzimología , Niño , Preescolar , Femenino , Frecuencia de los Genes , Estudios de Asociación Genética , Humanos , Masculino , Estrés Oxidativo , Superóxido Dismutasa/sangre , Superóxido Dismutasa/metabolismo , Valina/genética
4.
Eur J Ophthalmol ; 20(1): 106-14, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-19927269

RESUMEN

PURPOSE: To evaluate the anterior segment examination findings and the response to medical therapy of patients who had toxic anterior segment syndrome (TASS) after uncomplicated cataract surgery. METHODS: Fourteen eyes of 14 patients were enrolled in the study. Visual acuity, biomicroscopic anterior segment examination, intraocular pressure measurement, and fundus examination were performed to assess TASS occurring during postoperative 12-48 hours after uncomplicated phaco surgery. The visual impairment, corneal edema, tyndallization, fibrin formation, hypopyon, vitritis, and response to steroid therapy were evaluated prospectively. RESULTS: After topical steroid therapy lasting for 1 week, visual acuity improved in 11 eyes. No significant visual improvement occurred in 3 eyes. Significant corneal edema was found in 4 and mild corneal edema was observed in the other 10 eyes. Fibrin reaction occurred in 5 and tyndallization in various degrees was positive in all eyes. There was a 1-mm hypopyon in 1 patient. There was no sign of vitritis and steroid therapy was effective in all of the patients. In addition to topical treatment with steroid and antibiotic drops; systemic and subconjunctival steroids were used in 3 patients who had fibrin formation and in one patient who had hypopyon . CONCLUSIONS: After uncomplicated cataract surgery, toxic anterior segment may occur in the early postoperative period, which is treated successfully with steroids. More studies are needed to understand the multifactorial risk factors affecting the etiopathogenesis of this syndrome.


Asunto(s)
Segmento Anterior del Ojo/patología , Endoftalmitis/etiología , Implantación de Lentes Intraoculares , Facoemulsificación , Complicaciones Posoperatorias , Anciano , Edema Corneal/tratamiento farmacológico , Edema Corneal/etiología , Endoftalmitis/tratamiento farmacológico , Glucocorticoides/administración & dosificación , Humanos , Presión Intraocular/fisiología , Microscopía Acústica , Persona de Mediana Edad , Estudios Prospectivos , Factores de Riesgo , Síndrome , Agudeza Visual/fisiología
5.
Toxicol Ind Health ; 25(6): 429-34, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19671636

RESUMEN

In this study, we aimed to investigate the possible protective effects of caffeic acid phenethyl ester (CAPE) on lipid peroxidation (LPO) and the activities of antioxidant enzymes in the liver of rats exposed to the 900 MHz electromagnetic field (EMF). EMF of cellular phones may affect biological systems by increasing free radical, which appear mainly to enhance LPO, and by changing the antioxidative activities of liver, thus leading to oxidative damage. CAPE, an active component of propolis extract, exhibits antioxidant properties and several studies suggest that supplementation with antioxidant can influence EMF exposure induced hepatotoxicity. Thirty male Sprague-Dawley rats were divided into three groups: control (n = 10), 900 MHz EMF (n = 10) and 900 MHz EMF + CAPE (n = 10). CAPE was injected intraperitoneally for 30 days before exposure to EMF. Liver tissue was removed to study the activities of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), xanthine oxidase (XO) and the levels of LPO. The activities of XO, CAT and level of LPO increased in the 900 MHz electromagnetic field (EMF) group compared with the control group, although XO, CAT activities and LPO levels were decreased by 900 MHz EMF + CAPE administration. The activities of SOD and GSH-Px decreased in the 900 MHz EMF group compared with the control group, although their levels were increased by EMF + CAPE administration. It can be concluded that CAPE may prevent the 900 MHz EMF-induced oxidative changes in liver by strengthening the antioxidant defense system by reducing reactive oxygen species and increasing antioxidant enzyme activities.


Asunto(s)
Antioxidantes/farmacología , Ácidos Cafeicos/farmacología , Campos Electromagnéticos/efectos adversos , Hígado/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Animales , Modelos Animales de Enfermedad , Inyecciones Intraperitoneales , Peroxidación de Lípido/efectos de los fármacos , Peroxidación de Lípido/efectos de la radiación , Hígado/enzimología , Hígado/efectos de la radiación , Masculino , Estrés Oxidativo/efectos de la radiación , Oxidorreductasas/metabolismo , Ratas , Ratas Sprague-Dawley
6.
J Eur Acad Dermatol Venereol ; 23(7): 798-802, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19470047

RESUMEN

BACKGROUND: Psoriasis is associated with a premature atherosclerosis due to the chronic inflammatory process. To evaluate the effect of disease process on myocardial perfusion, we planned to perform 99mTc-MIBI myocardial perfusion single photon emission computed tomography (SPECT) in patients with psoriasis. METHODS: The study group consisted of 28 psoriasis patients (17 men, 11 women), aged 18-76 years, and mean age 41.2 +/- 14.1 years. The patients were selected among those who were older than 18 years and longer than 10 years of disease duration with more than two times of systemic treatment. All patients underwent 99mTc-MIBI myocardial perfusion SPECT with the same day protocol. RESULTS: We detected various risk factors including smoking habits in 7, family history of cardiovascular disease in 4, hypertension in 1, hyperlipidemia in 9 patients. We completed myocardial perfusion SPECT for each patient and found normal perfusion pattern in SPECT images. CONCLUSION: We detected that myocardial perfusion is preserved in the patients with psoriasis. The majority of acute heart attacks are caused by noncritical coronary stenosis and this may be an explanation for increased cardiovascular risk in these patients despite normal coronary perfusion.


Asunto(s)
Enfermedades Cardiovasculares/complicaciones , Circulación Coronaria , Psoriasis/patología , Adolescente , Adulto , Anciano , Enfermedades Cardiovasculares/fisiopatología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Psoriasis/complicaciones , Psoriasis/fisiopatología , Tomografía Computarizada de Emisión de Fotón Único , Adulto Joven
7.
Toxicol Ind Health ; 24(8): 519-24, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19039079

RESUMEN

The aim of this experimental study was to investigate the possible role of nitric oxide (NO) and the activities of adenosine deaminase (ADA) and xanthine oxidase (XO) in the pathogenesis of isoniazid (INH)-induced oxidative damage in red blood cells (RBCs), and also to show the effect of caffeic acid phenethyl ester (CAPE) and erdosteine, antioxidants, in decreasing this toxicity. A total of 25 adult male rats were divided into four experimental groups as follows: control group (n = 7), INH-treated group (n = 6), INH + CAPE-treated group (n = 6), and INH + erdosteine-treated group (n = 6). INH, INH-CAPE, and INH-erdosteine-treated groups were treated orally with INH 50 mg/kg daily and with the tap water for 15 days. Control group was given only tap water. CAPE was intraperitoneally injected for 15 days at a dose of 10 micromol/kg. Erdosteine was treated orally for 15 days at a dose of 10 mg/kg/day. The injection of INH led to a significant increase in the activities of ADA, XO, and NO levels in RBCs of rats. Co-treatment with CAPE caused a significant decrease in the activities of ADA and XO and the levels of NO in RBCs. In addition, co-treatment with erdosteine caused a significant decrease in the activities of ADA and XO and the levels of NO in RBCs. The results of this study showed that ADA, XO, and NO may play an important role in the pathogenesis of INH-induced oxidative stress in RBCs. CAPE and erdosteine may have protective potential in this process and they may become a promising drug in the prevention of this undesired side effect of INH.


Asunto(s)
Antioxidantes/farmacología , Antituberculosos/toxicidad , Ácidos Cafeicos/farmacología , Eritrocitos/efectos de los fármacos , Isoniazida/toxicidad , Óxido Nítrico/metabolismo , Purinas/metabolismo , Tioglicolatos/farmacología , Tiofenos/farmacología , Adenosina Desaminasa/metabolismo , Administración Oral , Animales , Modelos Animales de Enfermedad , Ingestión de Líquidos , Quimioterapia Combinada , Eritrocitos/metabolismo , Inyecciones Intraperitoneales , Masculino , Estrés Oxidativo/efectos de los fármacos , Alcohol Feniletílico/análogos & derivados , Ratas , Ratas Wistar , Xantina Oxidasa/metabolismo
8.
Pediatr Cardiol ; 27(3): 343-6, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16565903

RESUMEN

The objective of this study was to evaluate the prevalence of atrial septal aneurysm (ASA) in newborns, to define the natural course of ASA, and to investigate its role on closure of associated interatrial septal opening (IASO). A total of 1072 consecutive neonates were examined with echocardiography in the early postnatal period. The length of the interatrial septum, the diameter of IASO, the excursion and base of aneurysm, and the width of the related atrium were measured and the excursion ratio and the basal ratio were calculated for each neonate. Aneurysms with an excursion ratio > or = 25% were diagnosed as ASA. There were 81 neonates (7.6%) with ASA. The prevalence of ASA was 11.1% in preterm (14 of 126) and 7.1% in full-term newborns (67 of 946). All of the ASAs disappeared at the end of the first year of life, and there were no complications related to the lesion during the follow-up period. Although overall IASO prevalence was 78.6% (843 of 1072), it was 72.8% (59 of 81) among the cases with ASA. Although the disappearance time of interatrial septal shunt was not significantly different between the cases with and without ASA, spontaneous closure was less frequent in the cases with ASA than in those without ASA 77.7 and 96.1%), respectively (p < 0.001). The prevalence of ASA is high among newborns, with a high resolution rate. Therefore, it can be considered that it is benign and transient observation. Less frequent spontaneous closure of IASO in cases with ASA indicates that ASA may have a deleterious effect on spontaneous closure.


Asunto(s)
Aneurisma Cardíaco/epidemiología , Atrios Cardíacos , Defectos del Tabique Interatrial/epidemiología , Tabiques Cardíacos , Progresión de la Enfermedad , Ecocardiografía Doppler en Color , Femenino , Aneurisma Cardíaco/diagnóstico por imagen , Defectos del Tabique Interatrial/diagnóstico por imagen , Humanos , Recién Nacido , Masculino , Prevalencia , Estudios Prospectivos
9.
Cell Biol Toxicol ; 20(4): 213-9, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15499969

RESUMEN

Various studies indicate that the mycotoxin ochratoxin A (OTA) is a carcinogenic, genotoxic, teratogenic, immunotoxic, and nephrotoxic agent. In the present study, the activities of some enzymes in the serum and liver of rats with ochratoxicosis and the effects of melatonin on these enzymes were investigated. Rats were divided into three equal groups, each consisting of eight rats; control, OTA (289 microg/kg per day) and OTA + melatonin groups for this study. In the OTA treated group, the level of lipid peroxidation (LPO) and the activities of glutathione peroxidase (GSH-Px) were increased in the liver and serum in comparison with the control group. The activities of catalase (CAT) and superoxide dismutase (SOD) were significantly changed in the serum when compared with controls. Our results showed structural tissue damage in the liver in OTA-treated rats. Melatonin decreased the OTA-induced damage to support the antioxidant defense system and/or with free radical scavenger action.


Asunto(s)
Carcinógenos/toxicidad , Peroxidación de Lípido/efectos de los fármacos , Hígado/efectos de los fármacos , Ocratoxinas/toxicidad , Animales , Antioxidantes/análisis , Antioxidantes/metabolismo , Catalasa/sangre , Catalasa/metabolismo , Glutatión Peroxidasa/sangre , Glutatión Peroxidasa/metabolismo , Hígado/enzimología , Hígado/patología , Masculino , Melatonina/farmacología , Sustancias Protectoras/farmacología , Ratas , Ratas Wistar , Superóxido Dismutasa/sangre , Superóxido Dismutasa/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico
10.
Hum Exp Toxicol ; 22(7): 383-91, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12929728

RESUMEN

Nephrotoxicity and hepatotoxicity induced by Ochratoxin A (OTA) and ameliorating effects of melatonin were investigated in rats exposed to OTA. Experimental groups were as follows: control; OTA-treated; and OTA plus melatonin (MEL)-treated (OTA+MEL). The rats in the control group were administered with only a daily oral administration of 0.5 M NaHCO3. OTA was administered with a dose of 289 microg/kg in the same way. OTA and MEL were administered orally with OTA (289 microg/kg) and melatonin (10 mg/kg) in two different periods of time during the same day. The histopathologic changes in the liver and kidney tissues of control, OTA and OTA+MEL-treated rats were examined. There were no significant changes in the kidney and liver tissues of the control rats. Significant histopathologic changes were found in the kidney and liver tissue of rats treated with OTA. These were granular or vacuolated degeneration and necrosis of the liver cells, sinusoidal and central vein dilatation, bile duct proliferation, enlargement of periportal areas with mononuclear cell inflammatory infiltration and mild degree fibrous tissue proliferation, tubular epithelial cells degeneration, necrosis, proliferation and karyomegaly in the epithelial cells nuclei and peritubular and periglomerular lymphocyte infiltration, stromal fibrous tissue proliferation, hyperemic vessels. The severity of the lesions was significantly reduced by administration of melatonin. These results revealed that OTA induced significant histopathologic changes in liver and kidney tissue advocating OTA toxicity (P < 0.001), and administration of MEL+OTA significantly reduced the toxic effect of OTA on kidney and liver tissue of rats (P > 0.05).


Asunto(s)
Antioxidantes/farmacología , Carcinógenos/toxicidad , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Melatonina/farmacología , Ocratoxinas/toxicidad , Animales , Riñón/enzimología , Riñón/patología , Hígado/enzimología , Hígado/patología , Masculino , Micotoxinas/toxicidad , Ratas , Ratas Wistar
11.
Toxicol Pathol ; 29(4): 492-7, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11560255

RESUMEN

In this study, the possible toxic effects of Alternariol Methyl Ether (AME) and Tenuazonic Acid (TeA) produced by Alternaria species on esophagus of mice were investigated by using light and electron microscopy techniques. Mice were orally fed daily with AME or TeA for 10 months and at the end of this period, the effects of these chemicals on the esophageal mucosa were determined. By light microscopic examination, moderate and severe dysplasia characterized by loss of polarity, nuclear pleomorphism, and hyperchromasia were observed in TeA-treated animals. Electron-microscopic examination of TeA-treated mucosal epithelial cells revealed pyknosis in some nuclei, granulation and increase in chromatin mass, irregularities in the nuclear contours, vacuolization in nucleoplasms. and marked pleomorphism in the nuclei. In conclusion, our results suggested that TeA has higher toxicity as evidenced by dysplastic transformation.


Asunto(s)
Alternaria/metabolismo , Neoplasias Esofágicas/patología , Lactonas/toxicidad , Micotoxinas/toxicidad , Ácido Tenuazónico/toxicidad , Administración Oral , Animales , Peso Corporal/efectos de los fármacos , Núcleo Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Neoplasias Esofágicas/inducido químicamente , Neoplasias Esofágicas/ultraestructura , Masculino , Ratones , Micotoxinas/administración & dosificación , Factores de Tiempo
12.
Toxicol Lett ; 121(1): 9-13, 2001 Apr 08.
Artículo en Inglés | MEDLINE | ID: mdl-11312032

RESUMEN

Ochratoxin A (OA) is a nephrotoxic fungal metabolite (mycotoxin) occurring in foodstuffs. The compound is causally associated with mycotoxin porcine nephropathy, a disease comparable with a human kidney disease called endemic nephropathy. In this paper OA levels in the human serum samples collected from healthy individuals and individuals suffering from different urinary disorders in Isparta-Turkey are presented. OA was measured in serum samples of 40 healthy people and a total of 93 patients with different kinds of urinary disorders. Four different kinds of urinary disorders were represented: chronic renal failure treated by hemodialysis (35), chronic renal failure treated by peritoneal dialysis (28), patients with bladder cancer (15), patients with renal stones (15). Analysis of OA in human blood samples was performed using an analytical method based on the measurement of fluorescence spectra. The mean concentration of OA in the healthy group was 0.4 +/- 0.28 ng/ml. The highest mean concentration was found in the group of patients treated by hemodialysis, 2.1+/- 1.2 ng/ml. The mean concentrations of the toxin in all patients groups were higher compared to the control group. Also, a significant difference was found between the mean concentrations of the groups of patients treated by dialysis (hemodialysis or peritoneal dialysis) and of the patients with renal stones or bladder cancer, only with the exception of the difference between peritoneal dialysis and renal stones group. No other significant differences were found when comparing the two groups. The findings indicate that OA may have a role in the human urinary pathology considered herein. A higher level of OA in dialysis groups compared to the control, renal stones and bladder cancer groups could probably be explained by the reduced glomerular filtration rate of these patients.


Asunto(s)
Micotoxinas/sangre , Ocratoxinas/sangre , Enfermedades Urológicas/sangre , Adulto , Femenino , Humanos , Cálculos Renales/sangre , Enfermedades Renales/sangre , Fallo Renal Crónico/sangre , Neoplasias Renales/sangre , Masculino , Persona de Mediana Edad , Turquía , Neoplasias de la Vejiga Urinaria/sangre
13.
Eur J Nucl Med ; 26(8): 900-2, 1999 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10436204

RESUMEN

It has been shown that technetium-99m ethylenedicysteine ((99m)Tc-EC) clearance displays a strong correlation with orthoiodohippurate clearance and that it is possible to estimate effective renal plasma flow from (99m)Tc-EC clearance. However, in routine practice, when monitoring renal function of patients by clearance determinations it is imperative to test the reproducibility of the clearance technique in order to decide whether the changes in renal function are related to disease or not. The aim of this study was to test the reproducibility of (99m)Tc-EC clearance. The study group comprised 13 patients aged between 24 and 58 years (eight female and five male). Two patients had single kidneys due to agenesis and hypoplasia. Plasma creatinine and BUN levels were within the normal range and remained stable between two clearance studies. None of the patients were receiving medication. Two separate multiple sample clearance studies were performed in each patient within a week. The difference between two studies was expressed as a percentage of the mean value of the two studies, and the standard deviation of these percentages represented the precision. The plasma clearance of (99m)Tc-EC in the first-step studies ranged from 190 ml/min to 561 ml/min with a mean of 411+/-101 ml/min. The clearances obtained from the second-step studies ranged from 248 ml/min to 552 ml/min, with a mean of 387+/-94 ml/min. There was no statistically significant difference between the two clearance studies (P>0.05). There was a mean difference of 5.3% between the first and second clearance studies, and the precision was found to be 12.7%. In conclusion, this study suggested that consecutive (99m)Tc-EC clearance measurements should be interpreted cautiously.


Asunto(s)
Cisteína/análogos & derivados , Compuestos de Organotecnecio , Renografía por Radioisótopo , Radiofármacos , Adulto , Cisteína/farmacocinética , Femenino , Humanos , Riñón/fisiología , Masculino , Persona de Mediana Edad , Compuestos de Organotecnecio/farmacocinética , Radiofármacos/farmacocinética , Reproducibilidad de los Resultados
14.
J Nucl Med ; 38(11): 1784-6, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9374355

RESUMEN

UNLABELLED: Technetium-99m-EC has recently been introduced as an alternative renal tubular agent to 131I-ortho iodohippurate (OIH). It has been shown that 99mTc-EC clearance shows strong correlation with OIH clearance and it is possible to estimate effective renal plasma flow. In routine clinical studies, it is practical to use one or two plasma sample methods instead of multiple plasma samples for clearance determination. An attempt was made to determine 99mTc-EC clearance with one sample method. METHODS: Data from 72 subjects were collected. To increase the range of renal function, two anuric hemodialysis patients were also included. Clearances were determined by the open two-compartment model. RESULTS: The clearance range was 12 ml/min to 660 ml/min with a mean of 275 +/- 117 ml/min. Analysis of correlation was made by Tauxe's method. The least standard error of estimation (s.e.e. = 32.71 ml/min) and the best correlation (r = 0.97) between the theoretical volume distribution and the clearance estimations were obtained from the 54-min plasma sample. CONCLUSION: This study suggests that EC clearance could be determined by a simplified single-sample method with an acceptable s.e.e.


Asunto(s)
Cisteína/análogos & derivados , Riñón/diagnóstico por imagen , Compuestos de Organotecnecio , Radiofármacos , Insuficiencia Renal/diagnóstico por imagen , Adulto , Cisteína/sangre , Femenino , Humanos , Trasplante de Riñón/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Compuestos de Organotecnecio/sangre , Cintigrafía , Radiofármacos/sangre , Flujo Plasmático Renal Efectivo , Factores de Tiempo
15.
Int J Food Microbiol ; 11(3-4): 187-94, 1990 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-2282281

RESUMEN

Alternaria alternata strain 8442-3 was inoculated into tomatoes (Lycopersicon esculentum Mill.) and Red Delicious cultivar apples (Malus domestica Borkh.). Half of the lots of each fruit were shrink-wrapped in high-density polyethylene film. Wrapped and unwrapped fruits were incubated under darkness at 4, 15 and 25 degrees C for up to 5 weeks. A high-performance liquid chromatography method was developed to quantitate tenuazonic acid (TeA), alternariol (AOH), alternariol methyl ether (AME), and altenuene (ALT). Shrink-wrapping retarded, but did not completely inhibit growth in tomatoes for 3-7 days. Concentrations of up to 120.6 mg of AOH and 63.7 mg of AME per 100 g of tissue were produced in unwrapped tomatoes stored at 15 degrees C for 4 weeks; 19.0 mg of ALT per 100 g of tomato tissue was produced after 3 weeks at 25 degrees C. AOH, AME and ALT were also produced in unwrapped tomatoes stored at 4 degrees C; however, no TeA was detected in decayed tomatoes, regardless of type of wrapping or storage temperature. Shrink-wrapping resulted in decreased production of AOH, AME, and ALT. Alternaria toxins were not detected in apples stored at 4 and 15 degrees C. The highest concentration of AOH produced (48.8 mg per 100 g of tissue) was in unwrapped apples stored at 25 degrees C for 2 weeks; 12.3 mg per 100 g of tissue of shrink-wrapped apples was detected after 5 weeks of storage at 25 degrees C, while ALT reached 5.7 mg per 100 g after 4 weeks. TeA was not detected in apples infected with A. alternata.


Asunto(s)
Alternaria/metabolismo , Microbiología de Alimentos , Conservación de Alimentos , Frutas , Micotoxinas/biosíntesis , Cromatografía Líquida de Alta Presión , Lactonas/análisis , Micotoxinas/análisis , Solventes , Temperatura , Ácido Tenuazónico/análisis , Ácido Tenuazónico/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...